InvestorWire NewsRoom

InvestorNewsBreaks

NewsBreak Category: Cannabis
Friday Sep 08, 2023 - 12:23 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) ‘Strategically Important’ Patent Grants Protection in One of World’s Leading Oral Nicotine Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently celebrated the receipt of U.S. patent #11,700,875, titled “Compositions and Methods For Sublingual Delivery of Nicotine.” The patent covers various forms and sources of nicotine, including nicotine benzoate, nicotine polacrilex, nicotine citrate, nicotine detartrate, and many others, for use in sublingual delivery formats like oral pouches. “The new U.S. patent is remarkable…

Continue Reading

Friday Sep 08, 2023 - 11:58 am

InvestorNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Strengthening Position in Projected $51B Global Cannabis Market

Lucy Scientific Discovery (NASDAQ: LSDI) is featured in a recent FinancialNewsMedia (“FNM”) Editorial. The editorial provides an overview of LSDI’s position in a global cannabis market projected to hit $51 billion this year. According to the press release, the global cannabis market has seen consistent growth year after year, with increasing legalization of cannabis fueling that growth. The release notes that a recent Statista report…

Continue Reading

Thursday Sep 07, 2023 - 1:22 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 25th Annual Global Investment Conference

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing, and commercialization of rare cannabinoids and cannabinoid analogs, today announced its participation in the H.C. Wainwright Global Investment Conference, which is taking place Sept. 11-13, 2023, in New York City. The on-demand presentation by InMed’s CEO Eric A. Adams will be available beginning at 7 a.m. ET on Sept. 11 via webcast, and…

Continue Reading

Thursday Sep 07, 2023 - 11:04 am

InvestorNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquires High Times Intellectual Property, Featured in Financial News Media Article

Lucy Scientific Discovery (NASDAQ: LSDI) today announced the acquisition of the intellectual property (“IP”) of High Times, an iconic brand in the cannabis industry. In addition to the Hightimes.com domain, the transaction also includes the trademarks for the Cannabis Cup and 420.com brands and their respective domain names. In exchange, High Times will receive a 19.9% stake in Lucy's outstanding stock as well as performance-based…

Continue Reading

Wednesday Aug 30, 2023 - 12:42 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Update on IND Application Progress

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an update on the status of its anticipated submission of an Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) for the company’s planned U.S. phase 1b hypertension clinical trial designated as HYPER-H23-1. As previously announced, work that was mostly under Lexaria’s control such as batch manufacturing…

Continue Reading

Wednesday Aug 23, 2023 - 1:45 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes Launching IND Program on DehydraTECH-CBD for Hypertension

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that its groundbreaking research utilizing its patented DehydraTECH(TM)-processed cannabidiol (“DehydraTECH-CBD”) has been published in eight peer-reviewed articles across six different publications. “The most recent publication in June 2023 in the peer-reviewed International Journal of Molecular Sciences is ‘Differences in Plasma Cannabidiol Concentrations in Women and Men: A Randomized, Placebo-Controlled, Crossover Study.’…

Continue Reading

Wednesday Aug 23, 2023 - 12:28 pm

InvestorNewsBreaks – Alt Pro Expo to Take the Spotlight in Vegas

Alternative Products Expo (“Alt Pro Expo”), a renowned pioneer in hosting successful conferences throughout North and South America, today announced details for its upcoming event in the vibrant city of Las Vegas. The Las Vegas Expo 2023 is slated to take place at the expansive World Market Center, the largest event venue in downtown Las Vegas, from Sept. 14-16, 2023. The event has established a…

Continue Reading

Monday Aug 21, 2023 - 3:21 pm

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Announces Results of Annual Meeting

IGC Pharma (NYSE American: IGC) has announced that during its annual meeting of stockholders scheduled for and convened on Aug. 18, 2023, (the “annual meeting”), all proposals as disclosed on the Definitive Proxy Statement on Schedule 14A filed with the SEC on July 26, 2023, were passed by the requisite vote of the stockholders. Only stockholders of record as of the record date of June…

Continue Reading

Tuesday Aug 15, 2023 - 12:28 pm

InvestorNewsBreaks – GRN Holding Corporation (GRNF), One World Legends Enter Strategic Joint Venture

GRN Holding Corporation (OTC: GRNF) and Marijuana Inc., having recently merged into a consolidated entity, today announced a joint venture with One World Legends (“OWL”), a distinguished player in the cannabis sector. The partnership marks a significant step forward in shaping the future of the cannabis industry and fostering innovation, growth and global collaboration. “We have been working with One World Legends for two years…

Continue Reading

Wednesday Aug 09, 2023 - 12:22 pm

InvestorNewsBreaks – Sustain SoCal Announces IBN as Media Sponsor for Upcoming Annual Water Solution Event

Sustain SoCal, a nonprofit organization, is partnering with IBN (InvestorBrandNetwork), an innovative corporate communications firm and content distributor, for its upcoming annual Water Solutions 8 (“WS8”) event. IBN will serve as media sponsor for the water solutions series, which is returning for the eighth year. The in-person event is scheduled for Aug. 24, 2023, in Irvine, California. According to the announcement, Sustain SoCal has built…

Continue Reading

Wednesday Aug 09, 2023 - 12:01 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Results from Human Oral Nicotine Study Evaluating DehydraTECH(TM)-Nicotine

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting results from its 2023 human oral nicotine study NIC-H22-1. The study compared Lexaria’s DehydraTECH(TM)-Nicotine tobacco-free pouch to two world-leading brands: ZYN(R) and on!(R) ZYN(R) is from Swedish Match and on! comes from Altria Group Inc. subsidiary Helix Innovations LLC. According to the report, DehydraTECH-Nicotine reached maximum blood saturation levels faster than either…

Continue Reading

Thursday Aug 03, 2023 - 3:06 pm

InvestorNewsBreaks — Green Label Summit 2023 to Showcase Insights and Innovations Shaping the Future of Cannabis

The highly-anticipated Green Label Summit 2023, hosted by Jotia Group, is set to shine in the shimmering lights of Las Vegas on Sept. 13 - 14 at The Expo, World Market Center. The event is designed to deliver an unparalleled platform for dynamic discussions and visionary insights into the ever-evolving cannabis industry. The summit will feature the Psychedelic Horizons Forum, captivating sessions and masterclasses, with…

Continue Reading

Wednesday Aug 02, 2023 - 12:29 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Designing Human Clinical Study of DehydraTECH-CBD for Weight Loss, Diabetes Control

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today reported its intention to conduct a human clinical study to examine DehydraTECH-CBD for purposes of diabetes control and weight loss. Lexaria previously announced that, in its pre-clinical diabetes study DIAB-A22-1 in obese diabetic-conditioned animals, DehydraTECH-CBD achieved each of the following: lowered blood glucose levels by 19.9%; lowered overall body weight by 7%…

Continue Reading

Wednesday Aug 02, 2023 - 11:23 am

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Expands Phase 2 Trial to Add New Site

IGC Pharma (NYSE American: IGC) today announced the addition of an important trial site at the University of Puerto Rico network as an expansion of its ongoing phase 2 clinical trial investigating lead drug asset, IGC-AD1, as a treatment for lowering agitation in patients with Alzheimer’s disease. According to clinicaltrials.gov, IGC-AD1 is the only natural THC-based investigational drug undergoing FDA trials. The therapy relies on…

Continue Reading

Friday Jul 28, 2023 - 12:34 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW) Announces New Subsidiary, Provides Update on Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has incorporated a new wholly owned subsidiary: Lexaria Nutraceutical Corp., or LEXX Nutra. According to the announcement, LEXX Nutra was established to support Lexaria’s overall strategy of maximizing the potential for its patented DehydraTECH(TM) technology in a variety of markets. The company issued an exclusive perpetual license to LEXX Nutra, giving the new subsidiary rights…

Continue Reading

Friday Jul 21, 2023 - 11:10 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs. The company today announced that Jerry Griffin, VP of Sales and Marketing for InMed’s subsidiary BayMedica LLC, a leading supplier of bioidentical rare cannabinoids to the health and wellness (“H&W”) market, will be participating in a fireside chat with Water Tower Research on July…

Continue Reading

Thursday Jul 20, 2023 - 10:30 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today provided a commercial and manufacturing update on its subsidiary BayMedica LLC, a leading supplier of bioidentical rare cannabinoids to the health and wellness (“H&W”) market. Among the highlights, the company reported a 123% quarter-over-quarter increase in revenues. “We are very encouraged to see another…

Continue Reading

Wednesday Jul 19, 2023 - 11:24 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Portfolio in Oral Nicotine Delivery Sector

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it was granted a strategically important new patent in the oral nicotine sector by the United States Patent and Trademark Office (“USPTO”). According to the update, U.S. patent #11,700,875 Compositions and Methods For Sublingual Delivery of Nicotine includes claims for many types of nicotine, including nicotine benzoate, nicotine ditartrate, nicotine…

Continue Reading

Tuesday Jul 18, 2023 - 11:01 am

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Presenting 6 Posters on Its Lead Therapeutic Candidate at AAIC 2023

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, today announced that it is presenting six in-person posters highlighting data from its phase 1 clinical trials investigating the company’s lead therapeutic candidate, IGC-AD1, at the Alzheimer’s Association International Conference (“AAIC”). The event is taking place July 16-20, 2023, in Amsterdam, Netherlands. “We are honored to have six posters accepted for presentation at AAIC 2023, a…

Continue Reading

Friday Jul 14, 2023 - 2:22 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Study Reveals ‘Most Convincing Evidence’ of CBD’s Anti-Inflammatory Actions in Humans

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced additional findings from its human clinical study HYPER-H21-4, completed last year. “The hypertension study sought to evaluate DehydraTECH-processed cannabidiol (“CBD”) as a potential antihypertensive medication and already achieved primary efficacy and safety objectives. According to the company, the study also demonstrated significant reductions in several pro-inflammatory biomarkers – interleukin (‘IL’) 8, 10 and 18 – known to be…

Continue Reading

Thursday Jul 13, 2023 - 2:35 pm

InvestorNewsBreaks — Lift Events and Experiences Announces Inaugural US Cannabis Food & Beverage Event

Lift Events and Experiences will be hosting its first U.S. event: Lift San Francisco. The two-day event will be held on Aug. 3–4, 2023, at the Moscone Convention Center in San Francisco. According to the announcement, the event will feature the inaugural Taste at Lift: Cannabis Food & Beverage Experience, which is designed to allow attendees to participate in exclusive demos, in-depth presentations and expert panels…

Continue Reading

Thursday Jul 06, 2023 - 12:38 pm

InvestorNewsBreaks – Alt Pro Expo to Take the Stage in Dallas

Following successful events in North and South America, the Alternative Products Expo (“Alt Pro Expo”), a production of ZJ Events, is coming to the vibrant city of Dallas, Texas. The Dallas Expo 2023 is set to take place at the Kay Bailey Hutchison Convention Center in the heart of downtown from July 13-15, 2023. The center of retail distribution in the American southwest, Dallas is…

Continue Reading

Monday Jul 03, 2023 - 12:09 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Processed Formulation Results in Higher Concentration, Delivery of Estrogen Hormone than Control

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently completed its animal study HOR-A22-1, which showed that the company’s patented DehydraTECH(TM) technology platform significantly enhanced the oral delivery of the estrogen hormone estradiol. “The study found that the DehydraTECH-estradiol composition resulted in a maximum concentration in the bloodstream (‘Cmax’) of 5.65 ng/mL, which was approximately 900% higher than the control formulation’s…

Continue Reading

Thursday Jun 22, 2023 - 11:37 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) 755-201-EB Trial Demonstrates Clinically Important Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced safety and efficacy results from its phase 2 clinical trial. The purpose of the trial, called “755-201-EB,” was to evaluate the safety of INM-755 CBN cream, which consists of the control cream plus the active pharmaceutical ingredient CBN, and obtain preliminary evidence of…

Continue Reading

Tuesday Jun 20, 2023 - 2:04 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands IP Portfolio with Four New Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of four newly granted patents. The company secured two new Canadian patents, its 18th in its patent family No. 1: Food and Beverage Compositions Infused with Lipophilic Active Agents and Methods of Use Thereof, and No. 8 in its: Compositions Infused with Nicotine Compounds and Methods of Use Thereof.…

Continue Reading

Friday Jun 16, 2023 - 11:02 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on Promising Results from Diabetes Animal Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is releasing additional findings from its DIAB-A22-1 study, a diabetes animal study designed to evaluate the company’s proprietary DehydraTECH-CBD. DehydraTECH is a patented drug-delivery formulation and processing platform technology developed by Lexaria. The company noted that in addition to the three positive outcomes reported earlier — weight loss in obese diabetic-conditioned animals and improved triglyceride and…

Continue Reading

Monday Jun 12, 2023 - 12:55 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints Experienced Financial Professional as New CFO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the appointment of a new chief financial officer. Effective immediately, Mike Shankman will serve as outsourced CFO. An experienced accounting and finance professional, Shankman has held senior positions with companies in the biotechnology, medical devices and software-as-a-service industries. As a consultant with NOW CFO, one of his current clients is a…

Continue Reading

Friday Jun 09, 2023 - 10:39 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Portfolio of Worldwide Patents

Lexaria Bioscience Corp. (NASDAQ: LEXX), the global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs through its patented DehydraTECH(TM) technology, recently announced it had received notification of four newly awarded or allowed patents. “The new patents will add to Lexaria’s growing portfolio and, upon award, will bring the total number of patents granted worldwide to 32, with several…

Continue Reading

Tuesday Jun 06, 2023 - 12:30 pm

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Receives Notice of Allowance for Patent on IGC-501

IGC Pharma (NYSE American: IGC) today announced its receipt of a Notice of Allowance from the Commissioner of Patents, Canada, for its patent filing on the use of cannabinoids in the treatment of seizures (“IGC-501”). The formulation additionally received an intent to grant from the European Patent Office. With these and a previous award, the formulation for treating seizures is protected in the U.S., Canada…

Continue Reading

Thursday Jun 01, 2023 - 10:37 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Sponsored Research Presented at Canadian Neuroscience Meeting

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids, today announced that results from a neurodegenerative disease study were presented in a scientific poster at the Canadian Neuroscience Meeting in Montreal from May 28-31, 2023. The InMed sponsored research demonstrated the ability of a specific rare cannabinoid (“pCBx”) in InMed’s 900 Series library of potential candidates that…

Continue Reading

Friday May 26, 2023 - 11:49 am

InvestorNewsBreaks – Bright Green Corporation (NASDAQ: BGXX) Announces Pricing of $3.5M Private Placement

Bright Green (NASDAQ: BGXX) is one of the few companies selected by the U.S. government to grow, manufacture and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export. The company recently announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 3,684,210 shares of common stock and warrants to…

Continue Reading

Thursday May 25, 2023 - 11:12 am

InvestorNewsBreaks – Jaxx Cannabis Owner, Veteran and Cannabis Advocate Featured in Recent Episode of The Plant Lady

Female empowerer and owner of Jaxx Cannabis, JM Balbuena, was featured in a recent episode of The Plant Lady podcast. JM joined host Jackie Bryant to discuss her wellness brand and dispensary’s humble beginnings in San Diego county, which wanted to scrub cannabis culture from its image, to the company’s success, which JM attributes much to patience and working for the system instead of against…

Continue Reading

Tuesday May 23, 2023 - 1:29 pm

InvestorNewsBreaks – GRN Holding Corporation (GRNF), Marijuana Inc. Complete Merger, Positioning as Frontrunner in the Cannabis Industry

GRN Holding Corporation (OTC: GRNF) today announced successful completion of its merger with Marijuana Inc., solidifying a position as a dominant player in the cannabis industry. The milestone achievement marks a significant step forward in the shared vision of delivering high-quality cannabis products and driving innovation in the market. “We are delighted to announce the successful completion of the merger between GRN Holding Corporation and…

Continue Reading

Tuesday May 23, 2023 - 1:23 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Findings from DehydraTECH-CBD Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced additional findings from last year’s human clinical study HYPER-H21-4. The findings demonstrate significant reductions in several pro-inflammatory biomarkers known to be linked to cardiovascular disease (“CVD”) and a host of other conditions. “There is some pre-clinical evidence for the anti-inflammatory actions of CBD, but this is likely the most convincing evidence…

Continue Reading

Friday May 19, 2023 - 12:01 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO Featured in Upcoming Water Tower Research Fireside Chat

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be represented at an upcoming Water Tower Research Fireside Chat Series. The company announced that CEO Eric A. Adams will be the featured speaker at the May 23, 2023, fireside chat; the event is slated to begin at 1 p.m. ET. During the chat,…

Continue Reading

Thursday May 18, 2023 - 12:05 pm

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Announces Participation at Upcoming LD Micro Invitational

IGC Pharma (NYSE American: IGC) will be presenting at the 13th annual LD Micro Invitational, which is slated for June 6–8, 2023, in Los Angeles. IGC Pharma CEO Ram Mukunda and PFO Claudia Grimaldi will be leading the presentation, which is scheduled to begin at 3 p.m. PT on June 6. The event is in person, although individual presentations can be viewed virtually. An estimated…

Continue Reading

Monday May 15, 2023 - 2:57 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced financial results for the third quarter of the fiscal year 2023, which ended March 31, 2023. “The third quarter of fiscal year 2023 was an important period for InMed, as we achieved several key milestones across our different business segments, including completing enrollment…

Continue Reading

Friday May 12, 2023 - 10:57 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures $2M in Public Offering

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced the closing of its public offering of 2,106,000 units, with each consisting of one share of common stock and one warrant to purchase one share of common stock. Each unit was sold at a public offering price of $0.95. The warrants are immediately exercisable at a price of $0.95 per share…

Continue Reading

Thursday May 11, 2023 - 12:38 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Completion of cGMP Manufacturing for Upcoming Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced completion of batch manufacturing of the DehydraTECH(TM)-processed cannabidiol (“CBD”) and placebo materials for its upcoming U.S. phase 1b hypertension clinical trial HYPER-H23-1. According to the update, Lexaria retained the services of a U.S. contract manufacturing organization to produce the materials compliant with current Good Manufacturing Practice (“cGMP”) regulations as mandated by…

Continue Reading

Wednesday May 10, 2023 - 12:43 pm

InvestorNewsBreaks – Lift 2023 Event to Return to the Heart of Downtown Toronto

Lift Events & Experiences, Canada’s No. 1 cannabis conference and trade show series, today announced its return to the Metro Toronto Convention Centre (“MTCC”), a top-of-class venue for business event organizers, located in the heart of downtown Toronto. Lift Toronto 2023, slated to take place on June 1-3, is expected to attract representatives from more than 150 companies within the cannabis-value chain, 140+ renowned industry…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).